Lazard Asset Management LLC Crispr Therapeutics Ag Transaction History

Lazard Asset Management LLC

  • $63.4 Billion
  • Q2 2025

A detailed history of Lazard Asset Management LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Lazard Asset Management LLC holds 59,333 shares of CRSP stock, worth $3.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,333
Previous 63,690 6.84%
Holding current value
$3.63 Million
Previous $2.17 Million 33.13%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$31.27 - $48.64 $136,243 - $211,924
-4,357 Reduced 6.84%
59,333 $2.89 Million
Q1 2025

May 15, 2025
SELL
$34.03 - $53.02 $249,541 - $388,795
-7,333 Reduced 10.32%
63,690 $2.17 Million
Q4 2024

Feb 14, 2025
SELL
$38.65 - $55.15 $550,917 - $786,108
-14,254 Reduced 16.71%
71,023 $2.8 Million
Q3 2024

Nov 14, 2024
BUY
$44.62 - $62.75 $494,121 - $694,893
11,074 Added 14.92%
85,277 $4.01 Million
Q2 2024

Aug 14, 2024
SELL
$51.17 - $68.18 $610,816 - $813,864
-11,937 Reduced 13.86%
74,203 $4.01 Million
Q1 2024

May 14, 2024
SELL
$60.67 - $89.12 $663,729 - $974,972
-10,940 Reduced 11.27%
86,140 $5.87 Million
Q4 2023

Feb 14, 2024
SELL
$38.62 - $72.18 $711,921 - $1.33 Million
-18,434 Reduced 15.96%
97,080 $6.08 Million
Q3 2023

Nov 14, 2023
SELL
$45.39 - $59.0 $151,511 - $196,942
-3,338 Reduced 2.81%
115,514 $5.24 Million
Q2 2023

Aug 14, 2023
SELL
$43.47 - $67.77 $214,611 - $334,580
-4,937 Reduced 3.99%
118,852 $6.67 Million
Q1 2023

May 15, 2023
BUY
$41.0 - $56.12 $58,794 - $80,476
1,434 Added 1.17%
123,789 $5.6 Million
Q4 2022

Feb 14, 2023
SELL
$39.19 - $65.67 $4.05 Million - $6.79 Million
-103,369 Reduced 45.79%
122,355 $4.97 Million
Q3 2022

Nov 14, 2022
SELL
$61.1 - $83.78 $2.35 Million - $3.22 Million
-38,403 Reduced 14.54%
225,724 $14.8 Million
Q2 2022

Aug 09, 2022
BUY
$43.23 - $73.83 $3.93 Million - $6.71 Million
90,940 Added 52.51%
264,127 $16.1 Million
Q1 2022

May 13, 2022
BUY
$53.19 - $79.24 $2.25 Million - $3.36 Million
42,369 Added 32.39%
173,187 $10.9 Million
Q4 2021

Feb 09, 2022
BUY
$70.09 - $111.29 $5.09 Million - $8.07 Million
72,555 Added 124.53%
130,818 $9.91 Million
Q3 2021

Nov 15, 2021
BUY
$110.2 - $156.64 $301,286 - $428,253
2,734 Added 4.92%
58,263 $6.52 Million
Q2 2021

Aug 12, 2021
BUY
$100.84 - $161.89 $5.52 Million - $8.86 Million
54,755 Added 7074.29%
55,529 $8.99 Million
Q1 2021

May 14, 2021
SELL
$110.72 - $210.04 $8,414 - $15,963
-76 Reduced 8.94%
774 $94,000
Q4 2020

Feb 11, 2021
BUY
$79.67 - $173.23 $67,719 - $147,245
850 New
850 $130,000
Q2 2020

Aug 13, 2020
SELL
$38.5 - $76.05 $57,673 - $113,922
-1,498 Closed
0 $0
Q1 2020

May 14, 2020
BUY
$33.68 - $62.53 $50,452 - $93,669
1,498 New
1,498 $63,000

Others Institutions Holding CRSP

# of Institutions
545
Shares Held
68.5M
Call Options Held
3.67M
Put Options Held
2.25M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.77B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email